Musculoskeletal
circa 2600 BCE, ancient Egypt — Ebers Papyrus and related medical texts
Gout claimed a longer and more richly documented history than almost any other condition in Western medicine, with clear clinical descriptions dating back to ancient Egypt and Greece. For millennia, physicians and laypersons alike associated it with wealthy men who consumed rich food and wine in excess, an association that made it simultaneously a subject of medical inquiry and cultural commentary. The condition's history interwove genuine clinical observation with moral interpretation, as healers across centuries debated whether gout was a disease to be cured or a punishment to be endured.
Historical Narrative
The earliest written reference to a condition recognizable as gout appeared in Egyptian papyri dating to approximately 2600 BCE, where descriptions of a painful joint affliction in the great toe were recorded alongside herbal remedies. Ancient Egyptian physicians attributed such conditions to malign influences or imbalances in bodily substances, and their treatments involved poultices, incantations, and the application of plant-based preparations to the affected area.
Hippocrates, writing in the fifth century BCE, offered observations on the condition that demonstrated remarkable clinical acuity for his era. He noted that gout rarely afflicted women before menopause or eunuchs, observations that would not receive satisfactory physiological explanation for more than two thousand years. Hippocrates called it a disease of kings, reinforcing an association between affluence and affliction that would persist through the medieval period and into the modern era. Galen, writing in the second century CE, elaborated on humoral explanations for gout, attributing it to an accumulation of corrupt phlegm or black bile that settled into the joints. His theoretical framework, however inadequate by later standards, dominated European medical thinking about the condition for over a millennium.
Throughout the medieval period, European physicians continued to work within Galenic frameworks, recommending dietary restriction, purging, and bloodletting as means of expelling the offending humors. Islamic physicians, who preserved and extended Greek medical learning during the period when European scholarship declined, contributed nuanced observations about joint diseases. Ibn Sina, known in Europe as Avicenna, discussed gout in his encyclopedic Canon of Medicine and recommended colchicum, a plant extract derived from the autumn crocus, as a treatment — a practice that had roots in Byzantine medicine and would later be vindicated by modern pharmacology, though the mechanism remained unexplained in his era.
The seventeenth century brought a pivotal figure to the history of gout in the person of Thomas Sydenham, the English physician often called the English Hippocrates. Sydenham suffered from gout himself for much of his adult life and wrote about it with a combination of clinical precision and personal feeling that was unusual for the period. His 1683 Tractatus de Podagra et Hydrope provided a description of an acute gouty attack so vivid and exact that it was still quoted admiringly by medical writers into the twentieth century. Sydenham distinguished gout clearly from other joint conditions and pushed back against the prevailing tendency to regard it purely as a consequence of personal vice.
The chemical revolution in medicine during the eighteenth century transformed understanding of gout more profoundly than any development since antiquity. In 1776, the Swedish chemist Carl Wilhelm Scheele identified uric acid as a component of kidney stones, and subsequent researchers including William Hyde Wollaston in 1797 found that the chalky deposits in gouty joints, long known as tophi, were composed of urate crystals. This discovery provided the first chemical explanation for a condition that physicians had observed and speculated about for nearly three millennia. Alfred Baring Garrod, a nineteenth-century British physician, developed a thread test for detecting elevated uric acid in blood and published a landmark 1859 treatise establishing the connection between uric acid accumulation and the acute and chronic forms of the disease, laying the groundwork for all subsequent biochemical investigation.
Key Historical Figures
Historical narrative only — this page describes how Gout was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.